Frontiers | Targeting KRAS: The Elephant in the Room of Epithelial Cancers
IJMS | Free Full-Text | Gene Therapy Targeting p53 and KRAS for Colorectal Cancer Treatment: A Myth or the Way Forward?
Les biomarqueurs prédictifs dans le cancer colorectal
:quality(90)/ "Roche | Cancer du côlon : les principales mutations")
Roche | Cancer du côlon : les principales mutations
The Trouble With KRAS - Cancer Commons
Colorectal Cancer | Oncohema Key
Role of oncogenic KRAS in the prognosis, diagnosis and treatment of colorectal cancer | Molecular Cancer | Full Text
IJMS | Free Full-Text | Prognostic and Predictive Roles of KRAS Mutation in Colorectal Cancer
Study reveals potential target for precision colorectal cancer treatment - Redox Medicine Society
The Prognostic Impact of KRAS G12C Mutation in Patients with Metastatic Colorectal Cancer: A Multicenter Retrospective Observational Study - Chida - 2021 - The Oncologist - Wiley Online Library
Differential Reprogramming of Isogenic Colorectal Cancer Cells by Distinct Activating KRAS Mutations | Journal of Proteome Research
TAK1 Inhibition Promotes Apoptosis in KRAS-Dependent Colon Cancers - ScienceDirect
:max_bytes(150000):strip_icc()/kras-g12c-mutation-in-nsclc-4843957-v3-456bf340786c481b857d044b6a8cb307-b4828f2507074811b94472745e488299.png "KRAS Positive Lung Cancer: Testing and Management")
KRAS Positive Lung Cancer: Testing and Management
KRAS Codon 12 Mutation is Associated with More Aggressive Invasiveness | OTT
Biomarqueurs des cancers colorectaux utiles en pratique clinique – FMC-HGE
Integrated multi-omics characterization of KRAS mutant colorectal cancer
Therapeutic strategy in unresectable metastatic colorectal cancer: an updated review - Benoist Chibaudel, Christophe Tournigand, Franck Bonnetain, Hubert Richa, Magdalena Benetkiewicz, Thierry André, Aimery de Gramont, 2015
Colorectal Cancer
Identification of actionable alterations in colorectal cancer are leading to the development of novel treatment strategies - Mayo Clinic
Life | Free Full-Text | Integrated Decision-Making in the Treatment of Colon-Rectal Cancer: The Case of KRAS-Mutated Tumors
Prognostic role of KRAS mutations in Sardinian patients with colorectal carcinoma
Kras in metastatic colorectal cancer
Chemically modified MIR143-3p exhibited anti-cancer effects by impairing the KRAS network in colorectal cancer cells: Molecular Therapy - Nucleic Acids
Frontiers | Prognostic and therapeutic impact of the KRAS G12C mutation in colorectal cancer
KRAS mutation: from undruggable to druggable in cancer | Signal Transduction and Targeted Therapy
